← Back to All US Stocks

Ufp Technologies Inc. (UFPT) Stock Fundamental Analysis & AI Rating 2026

UFPT Nasdaq Surgical & Medical Instruments & Apparatus DE CIK: 0000914156
Recently Updated • Analysis: Apr 18, 2026 • SEC Data: 2025-12-31
BUY
85% Conf
Pending
Analysis scheduled

📊 UFPT Key Takeaways

Revenue: $602.8M
Net Margin: 11.3%
Free Cash Flow: $86.2M
Current Ratio: 2.68x
Debt/Equity: 0.32x
EPS: $8.75
AI Rating: BUY with 85% confidence
Ufp Technologies Inc. (UFPT) receives a BUY rating with 85% confidence from our AI fundamental analysis based on SEC 10-K filings. With revenue of $602.8M, net profit margin of 11.3%, and return on equity (ROE) of 16.1%, Ufp Technologies Inc. demonstrates strong fundamentals in the Healthcare sector. Below is our complete UFPT stock analysis for 2026.

Is Ufp Technologies Inc. (UFPT) a Good Investment?

Claude

UFP Technologies demonstrates strong fundamentals with 19.5% revenue growth and solid 11.3% net margins, supported by excellent free cash flow generation of $86.2M (14.3% FCF margin). The conservative capital structure (0.32x debt/equity) with robust 16.9x interest coverage provides financial stability and resilience. Growth quality is evident through earnings expanding at 15.8% while maintaining operational efficiency.

Why Buy Ufp Technologies Inc. Stock? UFPT Key Strengths

Claude
  • + Robust revenue growth (19.5% YoY) with profitable expansion across all margin levels
  • + Exceptional free cash flow generation ($86.2M annually) with 14.3% FCF margin demonstrating earnings quality
  • + Conservative leverage (0.32x debt/equity) with strong interest coverage (16.9x) providing financial flexibility
  • + Solid profitability metrics (28.3% gross margin, 15.3% operating margin) suggesting pricing power and operational efficiency
  • + Strong liquidity position (2.68x current ratio, 1.52x quick ratio) enabling operational stability

UFPT Stock Risks: Ufp Technologies Inc. Investment Risks

Claude
  • ! Low cash position ($20.3M) relative to asset base limits financial flexibility for acquisitions or crisis response
  • ! Insider activity with 11 Form 4 filings in last 90 days suggests potential shareholder actions requiring monitoring
  • ! Exposure to medical device sector regulatory risks and competitive pressures affecting margin sustainability

Key Metrics to Watch

Claude
  • * Free cash flow trends and working capital efficiency
  • * Gross and operating margin trajectory amid competitive pressures
  • * Debt reduction progress and leverage ratio trends
  • * Insider transaction patterns and directions

Ufp Technologies Inc. (UFPT) Financial Metrics & Key Ratios

Revenue
$602.8M
Net Income
$68.3M
EPS (Diluted)
$8.75
Free Cash Flow
$86.2M
Total Assets
$655.1M
Cash Position
$20.3M

💡 AI Analyst Insight

Strong liquidity with a 2.68x current ratio provides a solid financial cushion.

UFPT Profit Margin, ROE & Profitability Analysis

Gross Margin 28.3%
Operating Margin 15.3%
Net Margin 11.3%
ROE 16.1%
ROA 10.4%
FCF Margin 14.3%

UFPT vs Healthcare Sector: How Ufp Technologies Inc. Compares

How Ufp Technologies Inc. compares to Healthcare sector averages

Net Margin
UFPT 11.3%
vs
Sector Avg 12.0%
UFPT Sector
ROE
UFPT 16.1%
vs
Sector Avg 15.0%
UFPT Sector
Current Ratio
UFPT 2.7x
vs
Sector Avg 2.0x
UFPT Sector
Debt/Equity
UFPT 0.3x
vs
Sector Avg 0.6x
UFPT Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is Ufp Technologies Inc. Stock Overvalued? UFPT Valuation Analysis 2026

Based on fundamental analysis, Ufp Technologies Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.

Return on Equity
16.1%
Sector avg: 15%
Net Profit Margin
11.3%
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
0.32x
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

Ufp Technologies Inc. Balance Sheet: UFPT Debt, Cash & Liquidity

Current Ratio
2.68x
Quick Ratio
1.52x
Debt/Equity
0.32x
Debt/Assets
35.3%
Interest Coverage
16.85x
Long-term Debt
$135.5M

UFPT Revenue & Earnings Growth: 5-Year Financial Trend

UFPT 5-year financial data: Year 2025: Revenue $602.8M, Net Income $9.7M, EPS $1.27.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: Ufp Technologies Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $1.27 reflects profitable operations.

UFPT Revenue Growth, EPS Growth & YoY Performance

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
14.3%
Free cash flow / Revenue

UFPT Quarterly Earnings & Performance

Quarterly financial performance data for Ufp Technologies Inc. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2025 $145.2M $12.7M $2.11

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

Ufp Technologies Inc. Dividends, Buybacks & Capital Allocation

Operating Cash Flow
$91.9M
Cash generated from operations
Stock Buybacks
$587.0K
Shares repurchased (TTM)
Capital Expenditures
$5.7M
Investment in assets
Dividends
None
No dividend program

UFPT SEC Filings: Latest 10-K & 10-Q Analysis

Access official SEC EDGAR filings for Ufp Technologies Inc. (CIK: 0000914156)

📋 Recent SEC Filings

Date Form Document Action
Mar 12, 2026 4 xslF345X05/form4.xml View →
Mar 4, 2026 4 xslF345X05/form4.xml View →
Mar 4, 2026 4 xslF345X05/form4.xml View →
Mar 4, 2026 4 xslF345X05/form4.xml View →
Mar 4, 2026 4 xslF345X05/form4.xml View →

Frequently Asked Questions about UFPT

What is the AI rating for UFPT?

Ufp Technologies Inc. (UFPT) has an AI rating of BUY with 85% confidence, based on fundamental analysis of SEC EDGAR filings.

What are UFPT's key strengths?

Claude: Robust revenue growth (19.5% YoY) with profitable expansion across all margin levels. Exceptional free cash flow generation ($86.2M annually) with 14.3% FCF margin demonstrating earnings quality.

What are the risks of investing in UFPT?

Claude: Low cash position ($20.3M) relative to asset base limits financial flexibility for acquisitions or crisis response. Insider activity with 11 Form 4 filings in last 90 days suggests potential shareholder actions requiring monitoring.

What is UFPT's revenue and growth?

Ufp Technologies Inc. reported revenue of $602.8M.

Does UFPT pay dividends?

Ufp Technologies Inc. does not currently pay dividends.

Where can I find UFPT SEC filings?

Official SEC filings for Ufp Technologies Inc. (CIK: 0000914156) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is UFPT's EPS?

Ufp Technologies Inc. has a diluted EPS of $8.75.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is UFPT a good stock to buy right now?

Based on our AI fundamental analysis in April 2026, Ufp Technologies Inc. has a BUY rating with 85% confidence. The AI analysis suggests favorable fundamentals based on SEC filings. This is not investment advice.

Is UFPT stock overvalued or undervalued?

Valuation metrics for UFPT: ROE of 16.1% (sector avg: 15%), net margin of 11.3% (sector avg: 12%). Higher ROE suggests strong returns relative to peers.

Should I buy UFPT stock in 2026?

Our dual AI analysis gives Ufp Technologies Inc. a combined BUY rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is UFPT's free cash flow?

Ufp Technologies Inc.'s operating cash flow is $91.9M, with capital expenditures of $5.7M. FCF margin is 14.3%.

How does UFPT compare to other Healthcare stocks?

Vs Healthcare sector averages: Net margin 11.3% (avg: 12%), ROE 16.1% (avg: 15%), current ratio 2.68 (avg: 2).

Top Rated Stocks
NSSC 92% MLI 92% MELI 92% MDXG 92% MANH 92% INVA 92% GGG 92% GCT 92% FTNT 92% FSLR 92%
Sector: All Healthcare Stocks →
Browse: Buy Stocks High Confidence Stocks
Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Apr 18, 2026 | Data as of: 2025-12-31 | Powered by Claude AI